Skip to main content

Media Category: Evolution of Disease

Thomas Berger: Using MRI Wisely in Multiple Sclerosis – Practical Guidance for Everyday Clinical Practice

In this short video interview, Thomas Berger explains how MRI should be used pragmatically in the diagnosis and monitoring of multiple sclerosis. Watch the interview How should MRI be used pragmatically in the diagnosis and monitoring of multiple sclerosis in everyday clinical practice? Key points discussed include: The need for MRI protocols that are practical, efficient, and accessible for the majority of patients worldwide The central role of typical morphological changes on MRI (especially T2 lesion burden) in establishing diagnosis The importance of identifying...

Continue reading

Thomas Berger : Managing Multiple Sclerosis Relapses – From Accurate Diagnosis to Effective Treatment

In this short video interview, Thomas Berger explains how to accurately identify and manage relapses in multiple sclerosis, highlighting why correct assessment is fundamental for both acute treatment decisions and long-term disease management. Watch the interview How should MS relapses be assessed and treated? In the interview, Thomas Berger shares a practical, experience-based approach to relapse management, grounded in everyday clinical practice rather than theory alone. Key points discussed include: Why confirming a true relapse is the most critical prerequisite before...

Continue reading

Immune reconstitution – Clinical aspects: available and future treatment

Immune reconstitution therapies are reshaping modern MS management, offering periods of lasting disease control without continuous immunosuppression. In this thought-provoking session, Prof. Patrick Vermersch, leading MS clinician and clinical trial expert, examines how IRTs work in real clinical practice, what drives long-term success, and how to navigate risks, patient selection, and treatment timing. Drawing on decades of research and clinical experience, Prof. Vermersch provides a clear and clinically meaningful framework for understanding cladribine, alemtuzumab, HSCT, and...

Continue reading

New insights in the 2024 McDonald criteria: imaging biomarkers shaping MS diagnosis

In this keynote lecture at the Belgian MS Symposium 2025, Pietro Maggi discussed how advanced MRI biomarkers have been integrated into the upcoming 2024 revisions of the McDonald diagnostic criteria for Multiple Sclerosis. Key Insights from the Webinar: These revisions aim to improve diagnostic precision and reduce misdiagnosis, particularly in early or atypical cases. Among the most significant updates are: Optic nerve involvement — now recognized as a fifth anatomical location for demonstrating dissemination in space (DIS), supported by MRI, visual evoked potentials (VEP), and...

Continue reading

Translation of 2024 MS criteria for asymptomatic individuals into clinical practice: From RIS to MS

This recording will help you refine your MS diagnostic skills with Christine Lebrun-Frenay led-insights on the 2024 McDonald criteria and practical tools for confident early detection. Key Insights from the Webinar The 2024 McDonald revision refines diagnostic clarity in Multiple Sclerosis (MS) while maintaining strong continuity with the 2017 criteria. The update aims to support earlier, more confident diagnosis, particularly for asymptomatic or preclinical cases, and to reduce over-diagnosis in patients with vascular or migraine-related MRI findings. The session highlights how...

Continue reading

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.